Posted:
10/20/2025, 5:00:00 PM
Location(s):
England, United Kingdom
Experience Level(s):
Senior
Field(s):
Business & Strategy
Workplace Type:
Hybrid
Job Description
General Summary:
The Pricing & Market Access Director is responsible for leading the development and/or execution of Market Access strategies, in close collaboration with country Market Access teams, for one or more in-line/launch products, as well as partnering cross-functionally on commercial pipeline asset development strategies.
Key Duties and Responsibilities:
Knowledge and Skills:
Education and Experience:
#LI-SG1
#LI-Hybrid
Flex Designation:
Hybrid-Eligible Or On-Site EligibleFlex Eligibility Status:
In this Hybrid-Eligible role, you can choose to be designated as:
1. Hybrid: work remotely up to two days per week; or select
2. On-Site: work five days per week on-site with ad hoc flexibility.
Note: The Flex status for this position is subject to Vertex’s Policy on Flex @ Vertex Program and may be changed at any time.
Company Information
Vertex is a global biotechnology company that invests in scientific innovation.
Vertex is committed to equal employment opportunity and non-discrimination for all employees and qualified applicants without regard to a person's race, color, sex, gender identity or expression, age, religion, national origin, ancestry, ethnicity, disability, veteran status, genetic information, sexual orientation, marital status, or any characteristic protected under applicable law. Vertex is an E-Verify Employer in the United States. Vertex will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.
Any applicant requiring an accommodation in connection with the hiring process and/or to perform the essential functions of the position for which the applicant has applied should make a request to the recruiter or hiring manager, or contact Talent Acquisition at [email protected]
Website: http://www.vrtx.com/
Headquarter Location: Boston, Massachusetts, United States
Employee Count: 5001-10000
Year Founded: 1989
IPO Status: Public
Last Funding Type: Post-IPO Secondary
Industries: Biotechnology ⋅ Health Care ⋅ Medical ⋅ Pharmaceutical